F-18 16 Alpha-Fluoroestradiol Imaging in Predicting Response to First-Line Hormone Therapy in Women With Hormone Receptor-Positive Metastatic Breast Cancer - Related Studies

F-18 16 Alpha-Fluoroestradiol Imaging in Predicting Response to First-Line Hormone Therapy in Women With Hormone Receptor-Positive Metastatic Breast Cancer

This study is currently recruiting participants.

Study NCT00602043. Last updated on November 8, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		F-18 16 alpha-fluoroestradiol
		fludeoxyglucose F 18

5	Sponsors listed in this trial
		Fred Hutchinson Cancer Research Center
		National Cancer Institute (NCI)